Keybanc Maintains Overweight on Steris, Raises Price Target to $284
Benzinga Newsdesk 4 hours ago
Analyst RatingsNewsPrice Target
Keybanc analyst Brett Fishbin maintains Steris (NYSE:STE) with a Overweight and raises the price target from $269 to $284.
Keybanc analyst Brett Fishbin maintains Steris (NYSE:STE) with a Overweight and raises the price target from $269 to $284.